RxDoctor Payments Data

Mary Green

Family · Greenville, SCNPI 1245912542

Payments from drug & device makers

$3,824in general payments, 2019–2025

Across 126 payments — averaging $30.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$853
  • TG Therapeutics, Inc.$549
  • AbbVie$305
  • AstraZeneca$252
  • Novartis$185
  • Argenx US, Inc.$165
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$3,824100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,824 in reported general payments places this provider in the 85th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
MavencladCladribine19$1,472,326
RebifInterferon Beta-1a/Albumin11$135,283
Nurtec OdtRimegepant Sulfate27$30,674
Emgality PenGalcanezumab-Gnlm12$26,896
XcopriCenobamate12$15,928
Modafinil35$1,467
Tolterodine Tartrate ErTolterodine Tartrate17$1,000
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine25$886
Baclofen48$863
Duloxetine Hcl18$716
Valproic Acid12$541
Gabapentin58$536
Tizanidine Hcl27$439
Pregabalin36$429
Phenytoin Sodium Extended18$422

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
EMD Serono, Inc.Mavenclad, Rebif$853$1,607,60930 claims
PfizerNurtec Odt$128$30,67427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,248 family providers in South Carolina.

Other family in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →